Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

OBJECTIVES: To estimate the cost-effectiveness of a multidisciplinary diabetes management program using the Ontario Diabetes Economic Model (ODEM). METHODS: Using an Ontario-specific United Kingdom Prospective Diabetes Study Outcomes Model, changes in risk factors (e.g. glycosylated hemoglobin) were used to predict event rates for diabetes-related complications, costs and expected quality-adjusted life years (QALYs). Incremental cost-effectiveness ratios were calculated based on the cost of the program, projected cost and effectiveness over a lifetime. The base case assumed a 1-year treatment effect, 3% discount rate and 40-year time horizon. RESULTS: The ODEM estimated that improvements in risk factors prevented 16.2/1000 deaths and 15.5/1000 myocardial infarctions, and led to a 50% relative risk reduction in first amputations. The lifetime incremental cost per QALY gained in the base case was $5992. CONCLUSION: Short-term outcomes were improved, translating into avoidance of downstream complications; thus, the increased costs of program implementation were partly offset. Overall, the program represents a cost-effective method for managing type 2 diabetes.

Original publication





Canadian Journal of Diabetes

Publication Date





205 - 214